Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FOURTH MILITARY MEDICAL UNIVERSITY
- Publication Date
- 2012-03-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medical biotechnology, specifically relates to the technical fields of gene cloning, gene recombination, expression of foreign genes in prokaryotic cells, purification of target protein, etc. A method for constructing an antibody-based protein vaccine. Background technique
[0002] 1. Research on TNF-α molecules and anti-TNF-α therapy
[0003] 1.1 TNF-α molecule
[0004] In 1975, Carswell et al. found that there was a highly active tumor cytotoxic factor in the serum of mice infected with BCG and bacterial endotoxin, which could cause hemorrhagic necrosis of tumors, but had no killing activity on normal tissue cells, and named it tumor necrosis. Factor - TNF-α. The human TNF-α gene is located on chromosome 6. The gene is 4kb long and contains 4 exons. It is linked to the MHC gene. Its precursor consists of 232 amino acids and contains a signal peptide of 76 amino acids. The mouse gene is located on chromosome 1...